Invesco
IMNM icon

Invesco’s Immunome IMNM Stock Holding History

Invesco’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46M Sell
66,565
-203,500
-75% -$4.53M ﹤0.01% 2697
2025
Q4 		$5.8M Buy
270,065
+214,049
+382% +$3.76M ﹤0.01% 2172
2025
Q3 		$656K Buy
56,016
+27,224
+95% +$271K ﹤0.01% 3120
2025
Q2 		$268K Buy
28,792
+413
+1% +$3.39K ﹤0.01% 3412
2025
Q1 		$191K Buy
28,379
+1,718
+6% +$16.5K ﹤0.01% 3522
2024
Q4 		$283K Sell
26,661
-406,059
-94% -$4.91M ﹤0.01% 3429
2024
Q3 		$6.33M Buy
432,720
+406,783
+1,568% +$5.78M ﹤0.01% 2092
2024
Q2 		$314K Sell
25,937
-599,146
-96% -$9.37M ﹤0.01% 3477
2024
Q1 		$15.4M Buy
+625,083
New +$12.7M ﹤0.01% 1578

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Invesco's IMNM Position: Q1 2026 in Review

Invesco reduced its Immunome (IMNM) stake by 75% in Q1 2026, selling an estimated $4.53M and leaving 66,565 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2697.

Invesco first reported a position in IMNM in Q1 2024 and has held it in 9 quarters since. The position peaked at $15.4M in Q1 2024. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Invesco held 66,565 shares of Immunome worth $1.46M as of Q1 2026.
  • Invesco sold 203,500 Immunome shares in Q1 2026, an estimated $4.53M.
  • Immunome made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2697 holding.
  • Invesco first reported a position in Immunome in Q1 2024 and has held it in 9 quarters since.
  • Invesco's Immunome position peaked at $15.4M in Q1 2024.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.